United States Attorney's Office for the District of Nevada

07/17/2026 | Press release | Distributed by Public on 07/17/2026 17:20

Nevada Man Pleads Guilty to Smuggling and Selling Misbranded Erectile Dysfunction and Prescription Drugs

Press Release

Nevada Man Pleads Guilty to Smuggling and Selling Misbranded Erectile Dysfunction and Prescription Drugs

Defendant Earned Over $1.9 million From Selling Misbranded Prescription Drugs

LAS VEGAS - A Henderson, Nevada, man pleaded guilty today to smuggling misbranded prescription drugs containing sildenafil and tadalafil into the United States from India and selling them to stores in Nevada and elsewhere.

According to court documents and statements made in court, David Ralph Webber owned and operated Passion Plus Enterprises Inc. and Whole Science Health. He was not a registered pharmaceutical manufacturer with the U.S. Food and Drug Administration (FDA), nor was he licensed to administer prescription drugs or to be a wholesaler of prescription drugs.

Webber admitted that from at least 2018 to present he used his companies to import hundreds of thousands of misbranded prescription drug capsules and tablets containing sildenafil, sildenafil citrate, and tadalafil - the active ingredients in Viagra and Cialis - into the United States. The prescription drugs were manufactured in India at facilities that were not registered with the FDA. To evade customs detection and enforcement, Webber falsely declared that the wire transfers to the manufacturers were for business management consultancy services. He paid a packaging company to falsely label the capsules "Ride," "Kinky Kong," "Stif," "TBone," and "Kinky Pink"; to list false ingredients; and to falsely claim that the drugs were "100% Natural" and did not require a prescription.

Webber then sold the misbranded prescription drugs to smoke shops, convenience stores, and adult novelty stores in Nevada and elsewhere throughout the southwestern United States. He also sold them online to consumers through a website he operated. In total, he made more than $1.9 million in revenue from his sales of misbranded prescription drugs.

Webber pleaded guilty to a criminal information charging him with one count of introduction of a misbranded drug into interstate commerce and one count of mail fraud. Sentencing has been scheduled for October 19, 2026, before United States District Judge Jennifer A. Dorsey. He faces the maximum statutory penalty of 23 years in custody. A federal district court judge will determine any sentence after considering the U.S. Sentencing Guidelines and other statutory factors.

First Assistant United States Attorney Sigal Chattah for the District of Nevada, Special Agent in Charge Robert M. Iwanicki of the FDA's Office of Criminal Investigations Los Angeles Field Office, and the United States Postal Inspection Service (USPIS), Phoenix Division made the announcement.

This case was investigated by the FDA and USPIS. Assistant United States Attorneys Jessica Oliva and Kimberly Frayn are prosecuting the case.

###

Updated July 17, 2026
Topic
Prescription Drugs
Component
United States Attorney's Office for the District of Nevada published this content on July 17, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on July 17, 2026 at 23:20 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]